Automating Organic Synthesis (www.rowansci.com)

OnePot, a startup focused on automating organic synthesis, recently announced a $13 million seed funding round. Founded by Daniil Boiko and Andrey Tyrin, OnePot aims to address the "synthesis bottleneck" in small-molecule chemistry that has traditionally hindered the field. While existing methods rely heavily on human chemists, Boiko and Tyrin believe that integrating machine learning and an interdisciplinary approach can vastly improve the process, expanding the range of chemical reactions that can be automated. Their innovative model combines custom hardware, specialized machine learning tools, and a unique success-based pricing strategy that charges clients only for successful syntheses, making it more attractive for research and development. The significance of OnePot's work lies in its potential to transform drug discovery and material science, reducing the time and costs associated with synthesizing novel compounds. By harmonizing the chemistry and computational methods, OnePot not only aims to streamline the synthesis process but also aspires to enrich the library of accessible compounds, thereby accelerating innovation in pharmaceuticals and other industries. Their approach—seen as a step beyond mere automation—focuses on creating a flexible system capable of quickly adapting to new types of reactions and demands, thereby reshaping the landscape of chemical synthesis.